全文获取类型
收费全文 | 3946篇 |
免费 | 186篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 87篇 |
妇产科学 | 23篇 |
基础医学 | 502篇 |
口腔科学 | 64篇 |
临床医学 | 189篇 |
内科学 | 928篇 |
皮肤病学 | 77篇 |
神经病学 | 358篇 |
特种医学 | 167篇 |
外科学 | 620篇 |
综合类 | 15篇 |
预防医学 | 194篇 |
眼科学 | 90篇 |
药学 | 298篇 |
中国医学 | 4篇 |
肿瘤学 | 507篇 |
出版年
2023年 | 24篇 |
2022年 | 50篇 |
2021年 | 96篇 |
2020年 | 56篇 |
2019年 | 53篇 |
2018年 | 73篇 |
2017年 | 66篇 |
2016年 | 81篇 |
2015年 | 88篇 |
2014年 | 109篇 |
2013年 | 137篇 |
2012年 | 213篇 |
2011年 | 251篇 |
2010年 | 142篇 |
2009年 | 122篇 |
2008年 | 211篇 |
2007年 | 220篇 |
2006年 | 233篇 |
2005年 | 222篇 |
2004年 | 221篇 |
2003年 | 224篇 |
2002年 | 230篇 |
2001年 | 42篇 |
2000年 | 46篇 |
1999年 | 66篇 |
1998年 | 64篇 |
1997年 | 65篇 |
1996年 | 68篇 |
1995年 | 52篇 |
1994年 | 30篇 |
1993年 | 29篇 |
1992年 | 34篇 |
1991年 | 38篇 |
1990年 | 32篇 |
1989年 | 36篇 |
1988年 | 36篇 |
1987年 | 20篇 |
1986年 | 23篇 |
1985年 | 23篇 |
1984年 | 27篇 |
1983年 | 21篇 |
1982年 | 27篇 |
1981年 | 24篇 |
1980年 | 31篇 |
1979年 | 18篇 |
1978年 | 27篇 |
1977年 | 18篇 |
1975年 | 17篇 |
1974年 | 16篇 |
1967年 | 12篇 |
排序方式: 共有4151条查询结果,搜索用时 15 毫秒
41.
Yoshioka S Mitani H Maeda K Takeo S Matsuda K Katayama S Mizukawa R Kawahara R 《Brain research. Developmental brain research》2000,119(2):283-288
The effects of clonidine on the development of amygdaloid kindling were studied in rats of various ages (14, 21, 28 and 70 postnatal days). Administration of clonidine (0.2, 0.5 mg/kg i.p.) caused a significant retardation of kindling development in the 28-day-old rats as well as in the adult rats, whereas, in the 14-day-old rats, the development of kindling was significantly facilitated by clonidine. No significant effect of clonidine was observed in the 21-day-old rats. These results indicate that in rats the effects of clonidine on the development of amygdaloid kindling vary during development. 相似文献
42.
Takeo Shimo Naoki Ashizawa Koji Matsumoto Takashi Nakazawa Osamu Nagata 《Toxicological sciences》2005,87(1):267-276
The possible mechanism of the underlying nephropathy found in the rat toxicity study of FYX-051, a xanthine oxidoreductase inhibitor, was investigated. Rats received oral treatment of either 1 or 3 mg/kg of FYX-051, with and without citrate for four weeks to elucidate whether nephropathy could be caused by materials deposited in the kidney. Furthermore, analysis of the renal deposits in rats was also performed. Consequently, interstitial nephritis comprising interstitial inflammatory cell infiltration, dilatation, basophilia and epithelial necrosis of renal tubules and collecting ducts, deposits in renal tubules and collecting ducts, and so forth was seen in six of the eight rats and in all eight rats in the 1 and 3 mg/kg FYX-051 alone groups, respectively, with the intensity in the 3 mg/kg group being moderate to severe. In the simultaneous treatment with citrate group, however, no alterations were observed in the kidney, except for minimal interstitial nephritis in one instance in the 3 mg/kg FYX-051 + citrate group along with an increased urinary pH, leading to an increase in xanthine solubility. Analysis of intrarenal deposits showed that the entity would be composed of xanthine crystals. The present study, therefore, showed that nephropathy in rats occurring after the administration of FYX-051 was a secondary change caused by xanthine crystals being deposited in the kidney, and no other causes could be implicated in this kidney lesion. 相似文献
43.
Yumie Takeshita Yuki Kita Takeo Tanaka Hisanori Goto Yujiro Nakano Chisato Teramura Yasufumi Enyama Toshinari Takamura the Establishment of Rationale for Antiaging Diabetic Medicine Study Group 《Journal of diabetes investigation.》2022,13(6):965
Aims/IntroductionGlucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) might be less effective in patients with severe hyperglycemia, because hyperglycemia downregulated the GLP‐1 receptor in an animal study. To examine this hypothesis clinically, we compared the glucose‐lowering effects of GLP‐1 receptor agonist liraglutide with and without prior glycemic control.Materials and MethodsIn an open‐label, parallel trial, participants with poorly controlled type 2 diabetes were recruited and randomized to receive once‐daily insulin therapy, degludec (Insulin–GLP‐1 RA relay group, mean 16.8 ± 11.4 IU/day), for 12 weeks and then liraglutide for 12 weeks or subcutaneous injections of GLP‐1 RA, liraglutide (GLP‐1 RA first group, 0.9 mg), for 24 weeks. The primary efficacy end‐points consisted of changes in the levels of fasting plasma glucose and glycated hemoglobin (HbA1c).ResultsThe median fasting plasma glucose and HbA1c before the study were 210.0 mg/dL and 9.8%, respectively. The levels of fasting plasma glucose and HbA1c significantly decreased in the Insulin–GLP‐1 RA relay group (P < 0.001) and GLP‐1 RA first group (P < 0.001) by week 24, although no intergroup differences were observed. The reduction of HbA1c in the Insulin–GLP‐1 RA relay group tended to be larger than that in the GLP‐1 RA first group in the lowest CPR (C‐peptide immunoreactivity) quartile (P = 0.072). The adverse events consisted of gastrointestinal problems, followed by hypoglycemia.ConclusionsThe GLP‐1 receptor agonist is overall effective without prior glycemic control with insulin in participants with poorly controlled type 2 diabetes. However, in participants with insulinopenic type 2 diabetes, prior glycemic control with insulin might overcome glucose toxicity‐induced GLP‐1 resistance. 相似文献
44.
Masaham Kinoshita Yasuhiro Nakamura Ryuji Nakano Minoru Morimatsu Seiichi Fukuda Yasuhiro Nishimi Takeo Hashimoto 《Fetal and pediatric pathology》1989,9(4):445-457
The clinical features and morphological findings in 31 Japanese infants with trisomy 18 are presented. The majority were small-for-date infants. There was no sex predominance in our series, as opposed to male female ratios of 1:3 reported in the literature. The average age at death was greater in females than in males. Cardiovascular anomalies were consistently present; ventricular septar defect and patent ductus arteriosus being the most common malformations. Various other internal malformations including the Arnold-Chiari malformation were observed. 相似文献
45.
PURPOSE: To compare higher order wavefront aberrations in eyes implanted with acrylic aspherical intraocular lenses (IOLs) with a modified prolate anterior surface with conventional acrylic spherical IOLs by using the optical path difference method. METHODS: In a nonrandomized parallel cohort investigation, 36 eyes of 31 patients implanted with aspherical IOLs (Tecnis ZA9003) and 37 eyes of 23 age-matched patients implanted with spherical IOLs (SENSOR AR40e) were evaluated with a wavefront analyzer (OPD-Scan II) preoperatively and 1 month after surgery. The higher order aberrations for a 4.0-mm pupil diameter were expanded into Zernike's polynomial expression. Coma aberration, spherical aberration, and total higher order aberrations were evaluated as root mean square values. RESULTS: Postoperatively, coma and total higher order aberrations of spherical and aspherical IOLs significantly improved in both eyes. Spherical aberration improved in eyes with aspherical IOLs only (P < 0.01). CONCLUSION: After implantation of acrylic aspherical IOLs, postoperative higher order aberrations were not necessarily lower than after implantation of acrylic spherical IOLs, but compared with levels following implantation of acrylic spherical IOLs, a significant reduction in spherical aberration was achieved. 相似文献
46.
Ichiki M Kawasaki M Takayama K Ninomiya K Kuba M Iwami F Miyazaki N Oishi K Takeo S Aizawa H Nakanishi Y 《Cancer chemotherapy and pharmacology》2006,58(3):368-373
Purpose: This multicenter phase II study was conducted to investigate the efficacy and safety of carboplatin in combination with paclitaxel administered according to a biweekly schedule as a first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC). Patients and methods: Eligibility criteria included histologically or cytologically confirmed NSCLC (stage IIIb or IV), no prior treatment, and measurable or evaluable disease. Paclitaxel (140 mg/m2) was administered intravenously on day 1, in combination with carboplatin at an area under the concentration time curve (AUC) of 3, every 2 weeks. Results: Seventy-four patients (45 men) with a median age of 62 years (range 40–74) and a median ECOG performance status of 1 (range 0–2) were enrolled. The response rate was 35.1% [95% confidence interval (CI): 24.4–47.1%], with 26 partial responses. The median survival was 357 days, and the median time to progression was 218 days. Toxicity was generally mild; National Cancer Institute-Common Toxicity Criteria (NCI-CTC) grades 3 and 4 neutropenia was observeded in 50.0% of the patients, and grades 3 and 4 nausea/vomiting in 4.1%. Conclusions: Biweekly carboplatin combined with paclitaxel demonstrated anti-tumor activity in advanced NSCLC, with response and survival rates similar to those of carboplatin combined with paclitaxel administered every 3 weeks but with a more favorable toxicity profile, and the present data indicate that the regimen is suitable for use on an outpatient basis. 相似文献
47.
48.
49.
Crude habu venom decreased coronary perfusion pressure and produced a small increase in myocardial tension of isolated and perfused rat hearts. Indomethacin infusion depressed the fall in perfusion pressure caused by the venom, without affecting the increase in tension. Heated venom decreased perfusion pressure, but did not increase myocardial tension. These results suggest that crude habu venom has coronary vasodilating and positive inotropic effects, possibly through actions of a phospholipase A2 and a heat-labile component, respectively. 相似文献
50.